3 ms·
Well when the hepatitis C drug Sovaldi (sofosbuvir) was first introduced it cost $84K for a course of treatment, so $24K now is a lot less. And that is hardly t
by nradov 3y ago
Well when the hepatitis C drug Sovaldi (sofosbuvir) was first introduced it cost $84K for a course of treatment, so $24K now is a lot less. And that is hardly the only cure: several other pharmaceutical companies have brought competing drugs to market so there are multiple options.
https://www.statnews.com/2022/12/15/prisons-cant-afford-hep-c-drugs-but-some-figured-out-a-way/ https://www.statnews.com/2022/12/15/prisons-cant-afford-hep-...
Branded prescription drug prices are high mainly due to patent rights. But without patent exclusivity, most of those drugs wouldn't have been developed in the first place. It now often costs $1B+ to take a new candidate drug through phase-3 clinical trials; that money has to come from somewhere and private companies won't invest in that research unless they can expect to profit. The countries which impose strict price caps on prescription drugs generally don't do much new drug development. For example, during the past few years US drug companies have launched about twice as many new drugs compared to European countries.
https://www.efpia.eu/publications/downloads/efpia/the-pharmaceutical-industry-in-figures https://www.efpia.eu/publications/downloads/efpia/the-pharma...